Document Detail


Lack of modulation of gastric emptying by dietary nitrate in healthy volunteers.
MedLine Citation:
PMID:  19398876     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Nitric oxide produced endogenously in vagal neurons modulates gastrointestinal motor activity as an important non-adrenergic and non-cholinergic neurotransmitter. Other than through endogenous biosynthesis, a high concentration of nitric oxide also occurs by chemical reactions within the stomach in the presence of gastric acid through the entero-salivary re-circulation of dietary nitrate. Although dietary nitrate can be a potential source of nitric oxide in the human stomach, there has been no report on the effect of dietary nitrate on gastric motor function. The aim of this study is to investigate the effect of dietary nitrate on gastric emptying, one of the major parameters for the gastric motor function. Fifteen healthy volunteers underwent a placebo-controlled (310 mg sodium nitrate or placebo), double-blind, crossover trial. Since a sufficient amount of gastric acid is essential for dietary nitrate-derived nitric oxide generation in the stomach, the same protocol was repeated after 1-week treatment with a proton pump inhibitor, rabeprazole. Gastric emptying was evaluated by (13)C-octanoate breath test. The sodium nitrate ingestion did not affect gastric emptying either prior to or during rabeprazole treatment, although rabeprazole treatment itself significantly delayed gastric emptying, being independent of the dietary nitrate load. Confirmation of the delayed gastric emptying with rabeprazole indicates the sensitivity of the breath test employed in the present study. In conclusion, despite the potential nitrogen source of exogenous nitric oxide, the ingestion of 310 mg sodium nitrate, which is equivalent to the average daily intake of Japanese adults, does not affect gastric emptying in healthy volunteers.
Authors:
Shiho Terai; Katsunori Iijima; Kiyotaka Asanuma; Nobuyuki Ara; Kaname Uno; Yasuhiko Abe; Tomoyuki Koike; Akira Imatani; Shuichi Ohara; Tooru Shimosegawa
Related Documents :
922686 - Nitrosamines and nitrosamides in the etiology of gastrointestinal cancer.
350006 - Comparison of nitrite and dipslide methods for bacteriuria screening.
9607316 - Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide...
19270306 - Quantification of intermediates formed during the reduction of nitrite by deoxyhemoglobin.
19778036 - Bacteriogenic manganese oxides.
22436386 - Selenium-containing naphthalimides as anticancer agents: design, synthesis and bioactiv...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Tohoku journal of experimental medicine     Volume:  218     ISSN:  1349-3329     ISO Abbreviation:  Tohoku J. Exp. Med.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-28     Completed Date:  2009-05-26     Revised Date:  2013-04-16    
Medline Journal Info:
Nlm Unique ID:  0417355     Medline TA:  Tohoku J Exp Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  73-9     Citation Subset:  IM    
Affiliation:
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
2-Pyridinylmethylsulfinylbenzimidazoles / pharmacology
Adolescent
Adult
Anti-Ulcer Agents / pharmacology
Breath Tests
Caprylates / metabolism
Diet*
Gastric Emptying / drug effects,  physiology*
Humans
Male
Nitrates* / administration & dosage,  metabolism
Nitrites / metabolism
Saliva / chemistry
Young Adult
Chemical
Reg. No./Substance:
0/2-Pyridinylmethylsulfinylbenzimidazoles; 0/Anti-Ulcer Agents; 0/Caprylates; 0/Nitrates; 0/Nitrites; 124-07-2/octanoic acid; 32828355LL/rabeprazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  TGF-beta inhibits vascular sprouting through TGF-beta type I receptor in the mouse embryonic aorta.
Next Document:  Renal cell carcinoma: biological features and rationale for molecular-targeted therapy.